KURA
Kura Oncology, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +22.0% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +3 | 46.85M | $513.57M | +7 | −4 |
| Q1 2026 | 85 | 0 | 43.54M | $354.05M | +5 | −5 |
| Q4 2025 | 85 | 0 | 47.00M | $488.20M | +1 | −1 |
| Q3 2025 | 15 | -1 | 31.70M | $280.57M | — | −1 |
| Q2 2025 | 13 | 0 | 25.43M | $146.75M | — | — |
| Q1 2025 | 10 | 0 | 9.58M | $63.25M | — | — |
| Q4 2024 | 10 | -1 | 11.52M | $100.37M | +1 | −2 |
| Q3 2024 | 10 | 0 | 4.92M | $96.24M | +1 | −1 |
| Q2 2024 | 10 | — | 4.04M | $83.12M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 1.78M | +2.4% | $34.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 1.78M | +2.4% | $34.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.19M | +17.4% | $23.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 845.19K | +149.0% | $16.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 423.21K | +12.6% | $8.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 423.21K | +12.6% | $8.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 208.24K | -23.5% | $4.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 189.10K | Baru | $3.70M | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 122.52K | +50.0% | $2.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 122.52K | +50.0% | $2.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 122.52K | +50.0% | $2.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 106.11K | -12.4% | $2.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 37.30K | -16.8% | $728,880 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 37.30K | -16.8% | $728,880 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 37.30K | -16.8% | $728,880 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 37.30K | -16.8% | $728,880 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 23.73K | +2.9% | $464,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $3.70M | 0.0% |
Telah keluar
| Marshall Wace | $540,838 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 217 pemegang, 84.35M saham, $677.88M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Officer, Director · President and CEO · 100.00K lbr @ 12.39 · $1.24M
Officer, Director · President and CEO · 100.00K lbr @ 11.12 · $1.11M
Penjualan di pasar terbuka (S)
Officer · 4.34K lbr · $51,663
Officer · 31.49K lbr · $397,681
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi